JATT JATT II Acquisition Corp
$12.25▼ -0.89%
Financials
Other
After hours
$12.22▼ -0.24%
Sep 11, 7:30 PM ET
Volume 2.2K
Avg Volume (10D) 16.3K
Key Metrics & Fundamentals
Market Cap
$95.55M
P/E Ratio
–
Div Yield
–%
52W Range
9.99 - 23.76
% vs 50 MA
1.58%
% vs 200 MA
–%
RSI-14
49.3
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.41
Free Cash Flow
-$525,708
Gross Rev
$0
Gross Profit
$0
EBITDA
-$809,548
COGS
–
Operating Exp
$762,260
Operating Income
-$762,260
EBIT
-$762,260
Pretax Income
-$305,553
Net Income
-$305,553
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
GlobeNewswire · Aug 27, 2026 7:16 PM
JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
GlobeNewswire · Aug 25, 2026 11:00 PM
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
Pharmaceutical Technology · Jun 30, 2026 10:53 AM
Talawar Therapeutics to Go Public via Business Combination With JATT
MT Newswires · Jun 29, 2026 6:38 PM
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
PR Newswire · Jun 29, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See JATT's money flow as a full page
Social Sentiment
No Reddit posts found for JATT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.